| Aug 12 |
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 12 |
Y-mAbs Therapeutics GAAP EPS of -$0.21 misses by $0.06, revenue of $22.8M misses by $0.22M
|
| Aug 12 |
Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
|
| Aug 9 |
Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners’ Top Holdings Now?
|
| Aug 7 |
Y-mAbs to Participate in Upcoming Investor Conferences in August
|
| Aug 5 |
Y-mAbs Announces Second Quarter 2024 Conference Call and Webcast
|
| Jul 13 |
We're Not Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn
|
| Jul 2 |
MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
|
| Jul 1 |
Y-mAbs names Peter Pfreundschuh as CFO
|
| Jul 1 |
Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer
|
